4상모집 중
Study Evaluating Safety, Tolerability, and Metabolism of Niraparib
연구 개요
The purpose of this study is to identify the genetic characteristic(s), specifically degree of African ancestry, and environmental characteristic(s) that appear to be related to the effects, both good and bad, that the maintenance treatment has women with ovarian cancer. In this study, an investigational medication called niraparib is being tested for the treatment of ovarian cancer. Niraparib works by blocking the ability of cancer cells to fix their genes. Cancer cells with damaged genes have a harder time growing and spreading in the body and can even die.
- 스폰서
- 협력: GSK
- 적응증
- Ovarian Cancer
- 중재
- Niraparib
- 목표 등록
- 70명
- 시작일
- 2026-06-08
- 완료(예정)
- 2031-06-08
BioPulse가 제공하는 정보는 공개된 자료를 요약·정리한 것으로, 투자 조언이나 의료 조언이 아닙니다. 임상 데이터·규제 일정·공시 내용은 반드시 원문을 직접 확인하시기 바랍니다.